Table 3. Direct pairwise comparison results of esophageal cancer treatments.
Comparison | 3-year OS | 5-year OS | DFS | Recurrence | Metastasis |
---|---|---|---|---|---|
CT+S vs S | 0.88 (0.82, 0.93) | 0.81 (0.76, 0.86) | 0.76 (0.69,0.83) | 0.85 (0.73, 1.00) | 0.91 (0.72, 1.15) |
CRT+S vs S | 0.77 (0.69, 0.85) | 0.70 (0.63, 0.78) | 0.59 (0.53, 0.65) | 0.70 (0.45, 1.08) | 0.81 (0.58, 1.12) |
RT+S vs S | 1.05 (0.95, 1.15) | 1.09 (0.99, 1.18) | - | - | - |
CRT+S vs CT+S | 0.60 (0.44, 0.75) | 0.64 (0.49, 0.78) | 0.74 (0.50, 0.99) | 0.73 (0.44, 1.23) | - |
Abbreviation: OS-Overall survival, DFS-Disease-free survival.
Note: The data of 3-year OS, 5-year OS and DFS is HR (hazard ratio) and 95% confidence interval. The results of reccurence and matastasis are OR (odds ratio) and 95% confidence interval.